Video argues life insurers hold large mortality data for epigenetic aging research

Aging research has a data problem. Life insurance has the data. Roughly ten million life insurance policies are written in the United States every year, and four times that number globally. Every one arrives attached to deep phenotypic data — and eventually to the one outcome longitudinal research struggles hardest to capture: confirmed, adjudicated mortality. Insurers don't track it because it's interesting. They track it because they are contractually obligated to. That is at least three orders of magnitude more data than intervention studies in this field routinely collect. In this video I make the case that epigenetic researchers and life insurers need each other far more than either side currently realizes — and that the overlap between the two fields is almost empty. I'm Tom Nodine, founder of Human Life Expectancy. I came to this from the insurance side, and I've spent years walking toward the other one. Along the way: what would actually convince an insurer to test a hundred thousand people, which four areas of research are already clearing that bar, and the question almost no researcher has ever been asked — which door of the insurance industry does your work knock on? ── CHAPTERS ── 0:00 Why you might want an insurer 0:00 The overlap: a very small room 0:00 What the science keeps saying it needs 0:00 Three orders of magnitude 0:00 Should you be suspicious of me? 0:00 What fills the vacuum 0:00 Verification — Robert Philibert 0:00 Reliability — Raghav Sehgal 0:00 Responsiveness 0:00 Cost — TIME-seq 0:00 Two doors: underwriting and wellness 0:00 The invitation ── THE RESEARCHERS IN THIS VIDEO ── Robert Philibert — University of Iowa. Epigenetic verification of tobacco and alcohol use. Raghav Sehgal — Yale University. Reliability and responsiveness of epigenetic clocks. Jesse Poganik — Brigham and Women's Hospital / Harvard Medical School. TIME-seq. Andrea Cipriano — Stanford University. Full conversations with each of them: Verification of Tobacco Usage -- https://www.youtube.com/watch?v=LvMMnJFvLus&t=42s Reliability of epigenetic clocks → https://www.youtube.com/watch?v=DY2rOHued2A Responsiveness to interventions → https://www.youtube.com/watch?v=zuf6Bw4hGCk Driving down the cost of measurement → https://www.youtube.com/watch?v=E6KjC7udUOk ── THE RESEARCH ── Verification - "DNA methylation differentiates smoking from vaping and non-combustible tobacco use" Robert Philibert et. al. Epigenetics. 2022 Reliability — Sehgal et al., "Biological versus technical reliability of epigenetic clocks and implications for disease prognosis and intervention response." https://onlinelibrary.wiley.com/doi/10.1111/acel.70635 Responsiveness — Sehgal, Higgins-Chen et al., "Responsiveness of epigenetic aging biomarkers to longevity interventions in humans." Nature Aging, 2026. Fifty-one harmonized longitudinal intervention studies, sixteen clocks. Cost — Griffin, Kane, Trapp, Poganik et al., "TIME-seq." Nature Aging, 2024. Up to a hundred-fold reduction in the cost of methylation-based age measurement. TranslAGE platform, 179 harmonized DNA methylation datasets: https://www.translage.io/ Note: the within-person volatility result discussed in the reliability section is not yet published, and is shared with the authors' permission. ── FOR THE INSURANCE SIDE ── Most of this channel points the other way — what epigenetics can do for insurers. Better pricing, fewer misrepresentations, improved risk management, healthier policyholders who live longer. The long version is in my book, Revolutionizing Insurance with Epigenetic Testing: https://www.amazon.com/Revolutionizing-Health-Insurance-Epigenetic-Testing/dp/B0DM39JKM1/ref=sr_1_2?crid=2P1VDDQEJSD88&dib=eyJ2IjoiMSJ9.BtMJLYHIyh2If5Qpd89rmW25z8T6gy9DGJeud98KnEgZ3ysFdwfcs1qzqKFcU71r7r6aN6Rx8EzWh8DNBWkZszwWKZ_8WMOshUGlra1idVseDHuMlOB5oAJvJrO2JPRh-0mWzcnIclCbEIyksaN4u2f44b-QPePS_5prd75zPiq5ZbiW_fg_vAK-Pt7cu7qA4c7HfchZHekwuEpmPaCxhhg13Dze8yvctWrFiL1lXew.nzGEKmC2lP9meVCoJn2rcxe1r_MZt92LQti_K8diEgo&dib_tag=se&keywords=nodine+epigenetics&qid=1790814590&sprefix=nodine+Epigenetics%2Caps%2C132&sr=8-2 ── DISCLOSURE ── I run a company in this space. Human Life Expectancy is actively looking for commercially viable, scientifically robust applications of epigenetics, which means any researcher named in this video is someone I might end up doing business with. You should weigh that. I'd rather say it up front than have you find out later. ── ABOUT ── Human Life Expectancy brings epigenetic and biological age testing to the life insurance industry. This channel is about what is actually changing human life expectancy, and about the economics of who pays for it. https://www.humanlifeexpectancy.com What would you want measured, if someone could measure it a hundred thousand times? Tell me in the comments. #epigenetics #longevity #biologicalage